Evidence map›Paper›PMID 42163950›Full record

ArticleThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale2026

Seroprevalence of Coronavirus NL63 in Yamagata, Japan, Between 1976 and 2022.

Yohei Matoba, Naomi Ogawa, Tomoko Takahashi, Kenichi Komabayashi, Tatsuya Ikeda, Yoko Matsuzaki, Katsumi Mizuta

Abstract read
In one paragraph

Article in The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Seroprevalence of Coronavirus NL63 in Yamagata, Japan, Between 1976 and 2022.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yohei MatobaDepartment of Microbiology, Yamagata Prefectural Institute of Public Health, Yamagata, 990-0031, Japan.
Naomi OgawaDepartment of Microbiology, Yamagata Prefectural Institute of Public Health, Yamagata, 990-0031, Japan.
Tomoko TakahashiDepartment of Microbiology, Yamagata Prefectural Institute of Public Health, Yamagata, 990-0031, Japan.
Kenichi KomabayashiDepartment of Microbiology, Yamagata Prefectural Institute of Public Health, Yamagata, 990-0031, Japan.ORCID https://orcid.org/0000-0003-0900-8845
Tatsuya IkedaDepartment of Microbiology, Yamagata Prefectural Institute of Public Health, Yamagata, 990-0031, Japan.
Yoko MatsuzakiDivision of Infection Control, Yamagata University Hospital, Yamagata, 990-9585, Japan.ORCID https://orcid.org/0000-0003-2757-5886
Katsumi MizutaDepartment of Microbiology, Yamagata Prefectural Institute of Public Health, Yamagata, 990-0031, Japan.ORCID https://orcid.org/0000-0001-8965-9925

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in the epidemiology of seasonal coronavirus (CoV) are important for understanding CoV transmission dynamics and strengthening the strategies against emerging CoV infections. The epidemiology of CoV-NL63, a seasonal CoV discovered in 2003, is poorly understood, particularly before 2003. To analyze the seroprevalence of CoV-NL63 in Yamagata, Japan, we performed a microneutralization test using 146 to 379 serum samples collected from four age groups ranging from 0 to 4 years to ≥ 40 years in 1976, 1990, 2010, 2019, and 2022, as well as the Yamagata isolate. We only measured the neutralizing antibodies (NT Abs) against CoV-NL63, as methods for other seasonal CoVs had not yet been established. The total NT Ab-positive rate in each year was 68.0%-90.4%. The Ab-positive rates in 0-4-year age group were 21.3%-65.2% in each year, whereas the rates for individuals aged above 4 years old were between 73.3% and 100% throughout the study period. We do not understand the influence of cross-reactive immunity among seasonal CoVs. This study shows that seroprevalence against CoV-NL63 increased with age in the younger generation and then plateaued at a high level, suggesting that reinfection may occur and that CoV-NL63 was already transmitted among infants and children before CoV-NL63 had been identified.

Indexed as

acute respiratory infectionCoV-NL63seasonal coronavirusseroepidemiologyseroprevalence

Identifiers

PMID42163950
PMCPMC13184384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.